DOSSIER · 13F Holders · Q1 2026Healthcare · Biological Products, (No Diagnostic Substances)Inflation hedgeYield
KYMR
KYMERA THERAPEUTICS INC
271 institutions still hold KYMERA THERAPEUTICS INC as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 501575104·Biological Products, (No Diagnostic Substances)·271 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
271 institutions reported KYMR in Q1 2026. FMR LLC leads at 17.5% of the visible book. +46 net new institutions vs prior quarter — accumulation reading.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 14
251 more holders available. Log in →